Secondary |
Restless Legs Syndrome |
17.7% |
Pain |
17.2% |
Hypertension |
7.5% |
Coronary Artery Disease |
6.5% |
Osteoporosis |
4.3% |
Dyslipidaemia |
3.8% |
Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
Type 2 Diabetes Mellitus |
3.8% |
Asthma |
3.2% |
Chronic Myeloid Leukaemia |
3.2% |
Dizziness |
3.2% |
Hyperparathyroidism Secondary |
3.2% |
Hypothyroidism |
3.2% |
Nausea |
3.2% |
Prophylaxis |
3.2% |
Psychotic Disorder |
3.2% |
Renal Failure |
3.2% |
Vitamin Supplementation |
3.2% |
Contraception |
2.2% |
Hyperparathyroidism |
1.1% |
|
Transaminases Increased |
28.0% |
Ventricular Tachycardia |
16.0% |
Tachyarrhythmia |
8.0% |
Weight Decreased |
8.0% |
Dermatitis |
4.0% |
Drug Ineffective |
4.0% |
Dyspnoea Exertional |
4.0% |
Intentional Drug Misuse |
4.0% |
Pancytopenia |
4.0% |
Respiratory Distress |
4.0% |
Restlessness |
4.0% |
Somnolence |
4.0% |
Tremor |
4.0% |
Twin Pregnancy |
4.0% |
|
Concomitant |
Product Used For Unknown Indication |
40.8% |
Restless Legs Syndrome |
13.7% |
Hypertension |
11.1% |
Pain |
4.5% |
Rheumatoid Arthritis |
4.5% |
Drug Use For Unknown Indication |
3.0% |
Coronary Artery Disease |
2.6% |
Hyperparathyroidism Secondary |
2.6% |
Renal Impairment |
2.6% |
Osteoporosis |
1.9% |
Multiple Sclerosis |
1.6% |
Anaemia |
1.5% |
Nausea |
1.3% |
Anticoagulant Therapy |
1.2% |
Atrial Fibrillation |
1.2% |
Depression |
1.2% |
Diarrhoea |
1.2% |
Polyuria |
1.2% |
Surgery |
1.2% |
Hyperlipidaemia |
1.0% |
|
Hydrocephalus |
7.0% |
Pulse Absent |
7.0% |
Arthropathy |
5.6% |
Coagulation Time Abnormal |
5.6% |
Gastrointestinal Haemorrhage |
5.6% |
Hypotension |
5.6% |
Rheumatoid Nodule |
5.6% |
Ventricular Fibrillation |
5.6% |
Weight Decreased |
5.6% |
Anaemia |
4.2% |
Arterial Occlusive Disease |
4.2% |
Faecaloma |
4.2% |
General Physical Health Deterioration |
4.2% |
Pneumonia |
4.2% |
Pneumothorax |
4.2% |
Pyelonephritis |
4.2% |
Skin Ulcer |
4.2% |
Tachyarrhythmia |
4.2% |
Thinking Abnormal |
4.2% |
Tongue Ulceration |
4.2% |
|
Interacting |
Hypertension |
14.5% |
Pain |
12.7% |
Coronary Artery Disease |
10.9% |
Type 2 Diabetes Mellitus |
9.1% |
Dyslipidaemia |
7.3% |
Osteoporosis |
7.3% |
Prophylaxis Against Gastrointestinal Ulcer |
7.3% |
Restless Legs Syndrome |
7.3% |
Hyperparathyroidism Secondary |
5.5% |
Nausea |
5.5% |
Renal Failure |
5.5% |
Vitamin Supplementation |
5.5% |
Hyperparathyroidism |
1.8% |
|
Transaminases Increased |
100.0% |
|